LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
24h
Current
Min
249.82
Max
257.37
Income | 153M 1.3M |
---|---|
Sales | -11M 1.1B |
Profit margin | 0.114 |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +26.5% upside |
Next Earnings | 6 Aug 2025 |
---|
Market Cap | 22B |
---|---|
Previous open | 255.23 |
Previous close | 254.35 |
By Acuity
50%
50%
167 / 380 Healthcare
Past performance is not a reliable indicator of future results.
12 May 2025, 02:16 UTC
Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs
DJ
Read
29 Jan 2025, 15:59 UTC
ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene
DJ
Read
27 Nov 2024, 15:22 UTC
BeiGene Shares Up on EU Approval for Gastric, Esophageal Cancer Treatment
DJ
Read
21 Nov 2024, 14:45 UTC
Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK
DJ
Read
22 Oct 2024, 18:39 UTC
Indaptus Therapeutics Shares Rise After Pact to Develop Cancer Treatment
DJ
Read
7 May 2025, 10:07 UTC
BeiGene Maintains 2025 Expense Guidance of $4.1B to $4.4B >ONC
DJ
Read
7 May 2025, 10:06 UTC
BeiGene Backs 2025 Rev $4.9B-$5.3B >ONC
DJ
Read
7 May 2025, 10:05 UTC
BeiGene 1Q Net $1.27M >ONC
DJ
Read
7 May 2025, 10:04 UTC
BeiGene Says to Rename Company to BeOne Medicines >ONC
DJ
Read
7 May 2025, 10:02 UTC
BeiGene 1Q EPS $0.00 >ONC
DJ
Read
7 May 2025, 10:02 UTC
BeiGene 1Q Rev Increased 49% >ONC
DJ
Read
7 May 2025, 10:00 UTC
BeiGene 1Q Rev $1.12B >ONC
DJ
Read
27 Feb 2025, 11:07 UTC
BeiGene Sees 2025 Rev $4.9B-$5.3B >ONC
DJ
Read
27 Feb 2025, 11:06 UTC
BeiGene 4Q Global BRUKINSA Rev of $828M >ONC
DJ
Read
27 Feb 2025, 11:06 UTC
BeiGene 4Q Loss/Shr 11c >ONC
DJ
Read
27 Feb 2025, 11:06 UTC
BeiGene 4Q Rev $1.13B >ONC
DJ
Read
12 Nov 2024, 11:01 UTC
BeiGene 3Q Loss/Shr 9c >BGNE
DJ
Read
12 Nov 2024, 11:01 UTC
BeiGene 3Q Rev $1B >BGNE
DJ
Read
7 Aug 2024, 10:05 UTC
BeiGene 2Q Loss/Shr $1.15 >BGNE
DJ
Read
7 Aug 2024, 10:04 UTC
BeiGene 2Q Rev $929M >BGNE
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 326.72 USD 26.5%
High 359.47 USD
Low 259 USD
Based on 9 Wall Street analysts offering 12 month price targets forBeiGene Ltd ADR - Dist in the last 3 months.
By TipRanks
Strong Buy
9 ratings
8
Buy
1
Hold
0
Sell
Based on 9 analysts giving stock ratings to BeiGene Ltd ADR - Dist in the past 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Selling and administration expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Operating profit
$